Silver: The key to wound management?;L'argent fait-il le bonheur?

Pharmacien Hospitalier

Volumn 43, Issue 174, 2008, Pages 147-154

  Rohner, Célia ^a   Ethgen Bonnet, Morgane ^a,b   Monteiro, Marie Christine ^a   Wisniewski, Sandra ^a   Beretz, Laurence ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Pôle de Pharmacie Pharmacologie   (France)

Author keywords

Chronic wound management; Coated silver; Cytotoxicity; Resistance; Silver dressings; Silver sulfadiazine; Toxicity; Wound healing

Indexed keywords

ACTICOAT; ACTICOAT ABSORBENT; ACTISORB AG; ALTREET AG; AQUACEL AG; ASKINA CALGITROL; BIATAIN AG; CARBOXYMETHYLCELLULOSE; CELLOSORB AG; LALUSET PLUS; RELEASE AG; SILVER; SULFADIAZINE SILVER; UNCLASSIFIED DRUG; URGOTUL S AG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CITROBACTER FREUNDII; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOXICITY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; HUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS STUTZERI; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; WOUND DRESSING; WOUND HEALING;

EID: 53149113805     PISSN: 07689179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0768-9179(08)74198-1     Document Type: Article

References (46)

1. Maillard JY, Denyer SP. Focus on silver. EWMA Journal 2006 ; 6 (1) : 5-7.
2. Burrel RE. A scientific perspective on the use of topical silver preparations. Ostomy Wound Manage 2003 ; 49 (5A Suppl) : 19-24.
3. Silver S, Phung LT, Silver G. Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. J Ind Microbiol Biotechnol 2006 ; 33 : 627-34.
4. Klasen HJ. Historical review of the use of silver in the treatments of burns. I. Early uses. Burns 2000 ; 26 (2) : 117-30.
5. Leaper DJ. Silver dressings : their role in wound management. Int Wound J 2006 ; 3 : 282-94.
6. Klasen HJ. A historical review of the use of silver in the treatments of burns II. Renewed interest for silver. Burns 2001 ; 26 : 131-8.
7. Wright JB, Lam K, Hansen D, Burrell RE. Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999 ; 27 (4) : 344-50.
8. Friedman C, Bass E, Steinberg J. Diabetes watch : key considerations for utilizing silver dressings. Podiatry Today 2006 ; 19 (5) : 24-9.
9. Driver VR. Silver dressings in clinical practice. Ostomy Wound Manage 2004 ; 50 (9A suppl) : 11S-15S.
10. Parsons D, Bowler PG, Myles V, Jones S. Silver antimicrobial dressings in wound management : a comparison of antibacterial, physical, and chemical characteristics. Wounds 2005 ; 17 (8) : 222-32.
11. Maillard JY, Denyer SP. Démystifier l'argent. European Wound Management Association, document de référence : prise en charge de l'infection des plaies. 2006 ; 7-10.
12. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000 ; 52 (4) : 662-8.
13. Ovington LG. The truth about silver. Ostomy Wound Manage 2004 ; 50 (9A suppl) : 1S-10S.
14. Percival SL, Bowler PG, Russell D. Bacterial resistance to silver in wound care. J Hosp Infect 2005 ; 60 (1) : 1-7.
15. Brett DW. A discussion of silver as an antimicrobial agent : alleviating the confusion. Ostomy Wound Manage 2006 ; 52 (1) : 34-41.
16. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing : review of the literature. Burns 2007 ; 33 (2) : 139-48.
17. Documentation pharmaceutique - ConvaTec "Dossier technique Aquacel Ag®", 2007.
18. Site internet du laboratoire ConvaTec : http://www.convatec.com (consultation le 05/04/2007).
19. Documentation pharmaceutique - B-Braun «Askina® une gamme complète pour la prise en charge des plaies chroniques» 2006.
20. Site internet du laboratoire B.Braun : http://francais.bbraun.ch (consultation le 10/04/2007).
21. Documentation pharmaceutique - Johnson & Johnson "Actisorb plus®" 2006.
22. Site internet du laboratoire Johnson & Johnson : http://jnjgateway. com (consultation le 10/04/2007).
23. Documentation pharmaceutique - Coloplast "Accélérer la cicatrisation en douceur", octobre 2006.
24. Site internet du laboratoire Coloplast : http://www.coloplast.fr (consultation le 11/04/2007).
25. Site internet du laboratoire Urgo : http://urgomedical.com (consultation le 11/04/2007).
26. Téot L. Les topiques et pansements anti-infectieux à base d'argent. J Plaie Cicatrisation 2003 ; 39 (7) : 8-10.
27. Dossier pharmaceutique - Genevrier, "Ialuset plus®" 2006.
28. Dunn K, Edwards-Jones V. The role of Acticoat™ with nanocrystalline silver in the management of burns. Burns 2004 ; 30 (Suppl 1) : S1-9.
29. Haubold T, Birringer R, Lengeler B, Gleiter H. EXAFS studies of nanocrystalline materials exhibiting a new solid state structure with randomly arranged atoms. Phys Lett A 1989 ; 135 (8-9) : 461-6.
30. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early events in a porcine model of contaminated wounds : effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis and healing. Wound Rep Reg 2002 ; 10 : 141-51.
31. Tian J, Wong KK, Ho CM, et al. Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem 2007 ; 2 (1) : 129-36.
32. Fiches techniques Acticoat® et Acticoat Absorbent® - Smith&Nephew, juillet 2007.
33. Site internet du laboratoire Smith&Nephew : http://wound.smith- nephew.com/fr (consultation le 13/04/2007).
34. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis 2004 ; 17 : 91-6.
35. Ryan TJ. Infection following soft tissue injury : its role in wound healing. Curr Opin Infect Dis 2007 ; 20 : 124-8.
36. Ip M, Lui SI, Poon VK, Lung I, Burd A. Antimicrobial activities of silver dressings : an in vitro comparison. J Med Microbiol 2006 ; 55 (Pt 1) : 59-63.
37. Chopra I. The increasing use of silver-based products as antimicrobial agents : a useful development or a cause for concern ? J Antimicrob Chemother 2007 ; 59 : 587-90.
38. Thomas S, McCubbin P. Antimicrobial properties of ten silver-containing dressings, sous presse.
39. Thomas S, McCubbin P. An in vitro analysis of the antimicrobial properties of ten silver-containing dressings. J Wound Care 2003 ; 12 (8) : 305-8.
40. Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT. Topical silver for treating infected wounds (Review). Cochrane Database Syst Rev 2007 ; 24 (1) : CD005486.
41. Poon VK, Burd A. In vitro cytoxity of silver : implication for clinical wound care. Burns 2004 ; 30 (2) : 140-7.
42. Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C. Insuffisance rénale aiguë après application topique de sulfadiazine argentique. Ann Dermatol Venereol 2005 ; 132 (11 Pt 1) : 891-3.
43. Wan AT, Conyers RA, Coombs CJ, Masterton JP. Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 1991 ; 37 (10 Pt1) : 1683-7.
44. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 2006 ; 60 (3) : 648-52.
45. Baldi C, Minoia C, Di Nuici A, Capodaglio E, Manzo L. Effects of silver on isolated rat hepatocytes. Toxicol Lett 1988 ; 41 : 261-8.
46. Li XZ, Nikaido H, Williams KE. Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins. J Bacteriol 1997 ; 179 (19) : 6127-32.